HLS Therapeutics Appoints Craig Millian CEO to Head Company

marketwatch

2023-04-17

By Adriano Marchese

HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May.

The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.

Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA.

Write to Adriano Marchese at adriano.marchese@wsj.com

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2328089894"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2328089894\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2328089894?lang=zh_TW&edition=fundamental","thumbnail":"https://images.mktw.net/im-763164?size=1.777777777777778&width=220 220w","is_english":true,"pubTime":"2023-04-17 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2328089894","market":"us","top_or_hot":-1,"title":"HLS Therapeutics Appoints Craig Millian CEO to Head Company","media":"marketwatch","content":"<html><body><div itemprop=\"articleBody\" role=\"document\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <p>By Adriano Marchese</p><pre></pre> <p>HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May.</p> <p>The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.</p> <div> <p>Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA.</p><pre></pre> <p>Write to Adriano Marchese at adriano.marchese@wsj.com</p><pre></pre> </div> </div></body></html>","source":"mwatch_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HLS Therapeutics Appoints Craig Millian CEO to Head Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHLS Therapeutics Appoints Craig Millian CEO to Head Company\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">marketwatch</strong><span class=\"h-time small\">2023-04-17 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div itemprop=\"articleBody\" role=\"document\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <p>By Adriano Marchese</p><pre></pre> <p>HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May.</p> <p>The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.</p> <div> <p>Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA.</p><pre></pre> <p>Write to Adriano Marchese at adriano.marchese@wsj.com</p><pre></pre> </div> </div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.marketwatch.com/story/hls-therapeutics-appoints-craig-millian-ceo-to-head-company-62a399ea?mod=newsviewer_click\">marketwatch</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://www.marketwatch.com/story/hls-therapeutics-appoints-craig-millian-ceo-to-head-company-62a399ea?mod=newsviewer_click","article_id":"2328089894","we_media_id":null,"thumbnails":["https://images.mktw.net/im-763164?size=1.777777777777778&width=220 220w"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2328089894","pubTimestamp":1681731660,"columns":[],"sourceInfo":{"source_id":"mwatch_stock","name":"Market Watch"},"weMediaInfo":null,"summary":"By Adriano Marchese HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chi","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","TERN":"Terns Pharmaceuticals, Inc.","BK4191":"家用电器","CRCT":"Cricut, Inc.","BK4539":"次新股"},"translate_title":"HLS治疗任命克雷格米利安首席执行官领导公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRCT":0.83,"HLS":1,"TERN":0.83},"content_text":"By Adriano Marchese HLS Therapeutics Inc. said Monday that it appointed Craig Millian as its new chief executive officer, effective the beginning of May. The Toronto-based pharmaceutical company, which is focused on cardiovascular and central nervous system therapeutics, said Mr. Millian's appointment coincides with current CEO Gilbert Godin's retirement on May 1, and is the result of an extensive search conducted by the company board.  Mr. Millian served as chief operating officer at Corbus Pharmaceuticals Holdings Inc., and held commercial leadership positions at EMD Serono, the Canadian biopharmaceutical business of Merck KGaA. Write to Adriano Marchese at adriano.marchese@wsj.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}